Heather Preston, Director at Karuna Therapeutics, Inc. (KRTX), bought 350 shares at $72.36 ($25K) on 2020-09-04, disclosed to the SEC on 2020-09-09.
Open-market purchase of $25k KRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| KRTX | BUY | 2020-03-12 | $227K | — | Filing → |
| KRTX | BUY | 2020-01-10 | $56K | — | Filing → |
| KRTX | BUY | 2020-01-07 | $100K | — | Filing → |